Cha et al. reported that in a study of 692 breast cancer patients with invasive ductal carcinoma (IDC) and 114 invasive lobular carcinoma (ILC), the expression level of Beclin-1 was higher in IDC cases with higher proliferative activity [47]. Here, BECN1 is linked to breast cancer.